Chairman & CEO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Michael A Mussallem (insider trades) sold 22,850 shares of EW on 03/19/2020 at an average price of $177.78 a share. The total sale was $4.1 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $35.75 billion; its shares were traded at around $170.97 with a P/E ratio of 34.61 and P/S ratio of 8.35. Edwards Lifesciences Corp had annual average EBITDA growth of 16.30% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CEO Recent Trades:
- Chairman & CEO Michael A Mussallem sold 22,850 shares of EW stock on 03/19/2020 at the average price of $177.78. The price of the stock has decreased by 3.83% since.
Directors and Officers Recent Trades:
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,369 shares of EW stock on 03/06/2020 at the average price of $201.9. The price of the stock has decreased by 15.32% since.
- CVP, TAVR Larry L Wood sold 3,566 shares of EW stock on 03/02/2020 at the average price of $207. The price of the stock has decreased by 17.41% since.
- CVP, EMEA, Canada, Latin Amer Jean-luc M Lemercier sold 3,470 shares of EW stock on 02/27/2020 at the average price of $217.53. The price of the stock has decreased by 21.4% since.
For the complete insider trading history of EW, click here
.
